Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
- Creator: Sonnenblick, Amir , Francis, Prudence A. , Lluch, Ana , Gnant, Michael , Goldhirsch, Aron , Di Leo, Angelo , Barnadas, Agusti , Cortes-Funes, Hernan , Piccart, Martine , Crown, John , Azim Jr, Hatem A. , de Azambuja, Evandro , Nordenskjold, Bo , Gutierez, Jorge , Quinaux, Emmanuel , Mastropasqua, Mauro G. , Ameye, Lieveke , Anderson, Michael
- Resource Type: journal article
- Date: 2015
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial
- Creator: Fernández-Cuesta, Lynnette , Oakman, Catherine , Larsimont, Denis , Francis, Prudence A. , Crown, John , Piccart-Gebhart, Martine , Viale, Giuseppe , Leo, Angelo Di , Olivier, Magali , Falagan-Lotsch, Patricia , Smoth, Ke-seay , Quinaux, Emmanuel , Buyse, Marc , Dolci, M. Stella , Azambuja, Evandro De , Hainaut, Pierre , Dell'Orto, Patrizia
- Resource Type: journal article
- Date: 2012